Clinical Utility of Serum Ribonuclease 1(RNASE1) as a Biomarker of Lupus Nephritis.

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Enrollment: 128

Sponsor: Assiut University

Summary

This study will identify the level of serum Riboneuclease 1 in systemic lupus patients and compare between its level in lupus nephritis and non nephritis.

Eligibility Criteria

Inclusion Criteria: 1. Adult patients (≥18 years old) with non lupus nephritis SLE diagnosed according to the 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus . 2. Adult patients (≥18 years old) with Lupus Nephritis classified according to the 2018 ISN/RPS classification criteria. Exclusion Criteria: 1. Patients less than 18 years old 2. Patients with other autoimmune diseases 3. Active infection and malignancy 4. Pregnancy and lactation 5. Inability to provide informed consent

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07763821). StuddyBuddy aggregates publicly available trial information.